BRCA2 loss in Fanconi Anemia

被引：0
|
作者：
Weitzman J.B.
机构：
来源：
Genome Biology | / 3卷 / 1期
关键词：
Breast Cancer; Anemia; Cancer Susceptibility; Fanconi Anemia; Breast Cancer Susceptibility;
D O I：
10.1186/gb-spotlight-20020614-01
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [1] Biallelic inactivation of BRCA2 in Fanconi anemia
    Howlett, NG
    Taniguchi, T
    Olson, S
    Cox, B
    Waisfisz, Q
    de Die-Smulders, C
    Persky, N
    Grompe, M
    Joenje, H
    Pals, G
    Ikeda, H
    Fox, EA
    D'Andrea, AD
    SCIENCE, 2002, 297 (5581) : 606 - 609
  • [2] Biallelic inactivation of BRCA2 in Fanconi Anemia.
    Howlett, NG
    Taniguchi, T
    Olson, S
    Cox, B
    Waisfisz, Q
    de Die-Smulders, C
    Persky, N
    Grompe, M
    Joenje, H
    Pals, G
    Ikeda, H
    Fox, EA
    D'Andrea, AD
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 237 - 237
  • [3] Nonhematologic neoplasia in biallelic BRCA2 mutated Fanconi anemia.
    Chinnabhandar, Vasant
    Defor, Todd E.
    Tryon, Rebecca
    Wagner, John E.
    MacMillan, Margaret L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Quick glance at Fanconi anemia and BRCA2/FANCD1
    AlDallal, Salma M.
    AIMS MEDICAL SCIENCE, 2019, 6 (04): : 326 - 336
  • [5] Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
    Xia, Bing
    Dorsman, Josephine C.
    Ameziane, Najim
    de Vries, Yne
    Rooimans, Martin A.
    Sheng, Qing
    Pals, Gerard
    Errami, Abdellatif
    Gluckman, Eliane
    Llera, Julian
    Wang, Weidong
    Livingston, David M.
    Joenje, Hans
    de Winter, Johan P.
    NATURE GENETICS, 2007, 39 (02) : 159 - 161
  • [6] Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
    Bing Xia
    Josephine C Dorsman
    Najim Ameziane
    Yne de Vries
    Martin A Rooimans
    Qing Sheng
    Gerard Pals
    Abdellatif Errami
    Eliane Gluckman
    Julian Llera
    Weidong Wang
    David M Livingston
    Hans Joenje
    Johan P de Winter
    Nature Genetics, 2007, 39 : 159 - 161
  • [7] In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor
    van der Heijden, MS
    Brody, JR
    Dezentje, DA
    Gallmeier, E
    Cunningham, SC
    Swartz, MJ
    DeMarzo, AM
    Offerhaus, GJA
    Isacoff, WH
    Hruban, RH
    Kern, SE
    CLINICAL CANCER RESEARCH, 2005, 11 (20) : 7508 - 7515
  • [8] Fanconi anaemia and BRCA2 mutations
    Clancy, T
    Clayton-Smith, J
    Marchbank, NJ
    Lalloo, F
    Tischkowitz, M
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S20 - S20
  • [9] Hematopoietic cell transplantation in Fanconi anemia patients with biallelic BRCA2 mutations.
    MacMillan, ML
    Auerbach, AD
    Wagner, JE
    BLOOD, 2004, 104 (11) : 776A - 776A
  • [10] SiRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells
    Bruun, D
    Folias, A
    Akkari, Y
    Cox, Y
    Olson, S
    Moses, R
    DNA REPAIR, 2003, 2 (09) : 1007 - 1013
12345